National Institute of Biomedical Imaging and Bioengineering

From Wikipedia, the free encyclopedia
Jump to: navigation, search
National Institute of Biomedical Imaging and Bioengineering
US-NIH-NIBIB-Logo.svg
National Institute of Biomedical Imaging and Bioengineering Logo
Agency overview
Formed 2000 (2000)
Agency executive Roderic Pettigrew[1], Director
Parent agency National Institutes of Health
Website nibib.nih.gov

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is the newest of the National Institutes of Health (NIH) research institutes and centers and was formed in the United States when President Bill Clinton signed it into law on December 29, 2000.

The Institute is committed to integrating the physical and engineering sciences with the life sciences to advance basic research and medical care. This is achieved through: research and development of new biomedical imaging and bioengineering techniques and devices to fundamentally improve the detection, treatment, and prevention of disease; enhancing existing imaging and bioengineering techniques; advocating related research in the physical and mathematical sciences; encouraging research and development in multidisciplinary areas; developing technologies for early disease detection and assessment of health status; and developing advanced imaging and engineering techniques for conducting biomedical research at multiple scales.

Leadership[edit]

The director of the institute is Roderic Pettigrew, Ph.D., M.D.; the deputy director is Belinda Seto, Ph.D.; the scientific director of intramural research is Richard D. Leapman, PhD.

Notes and references[edit]

  1. ^ "Director's Page - NIBIB". nibib.nih.gov. Retrieved 2013-10-02. 

External links[edit]